AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report)’s stock price was down 11.9% on Friday. The stock traded as low as $1.4101 and last traded at $1.4450. Approximately 323,970 shares traded hands during mid-day trading, an increase of 308% from the average daily volume of 79,326 shares. The stock had previously closed at $1.64.
AIkido Pharma Price Performance
The firm has a market capitalization of $7.68 million, a price-to-earnings ratio of -0.36 and a beta of 0.93. The business’s fifty day simple moving average is $2.09 and its 200 day simple moving average is $2.86.
About AIkido Pharma
AIkido Pharma Inc is a development-stage biotechnology company focused on discovering and developing therapeutic products for serious diseases. Its activities have centered primarily on small-molecule drug candidates and early-stage pharmaceutical research rather than the sale of commercialized products.
The company has historically pursued programs in oncology, including research related to pancreatic cancer, as well as potential treatments for infectious diseases. AIkido Pharma has used licensing arrangements, research collaborations and other external partnerships to advance its development pipeline.
AIkido Pharma’s programs have generally remained in the preclinical or early development stages, and the company’s operations have been focused on research and development rather than broad commercial distribution.
See Also
- Five stocks we like better than AIkido Pharma
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
